View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pall Corporation
10 September 2018

Pall Corporation and Celltheon Form Strategic Partnership for Biotherapeutics Development 

Pall Corporation has formed a strategic partnership with experienced cell line and expression technology platform development company Celltheon Corporation.

This partnership aligns Pall Biotech’s equipment and consumables with the Celltheon SMARTTM Expression Platform to deliver integrated manufacturing solutions for customers developing biotherapeutics. The move is part of Pall’s strategic approach to forming key partnerships that help enable better, safer and faster biologic production.

Vice-president and general manager of Pall Biotech said: “The Pall Biotech portfolio was built to support drug manufacturers at all stages of biotherapeutic molecule development and processes to improve biologic production, and ultimately, global health.

“Pall’s strategic partnerships, such as this one with Celltheon, aim to overcome manufacturing challenges with efficient, integrated and cost-effective total solutions.”

CEO and founder and chairman of Celltheon Amita Goel said: “The CELLTHEON SMARTTM Expression Platform is an off-the-shelf, fully validated mammalian cell platform used to develop biologics and it is well complemented by the Pall Biotech line of equipment and services.

“With the complementary Celltheon and Pall technologies, we can provide an integrated end-to-end solution for research and bioproduction that is cost effective and time efficient. This partnership with Pall Corporation is in line with Celltheon’s mission to expedite drug development and provide solutions for unmet needs in bioprocessing.”

Through the agreement, Celltheon customers will have immediate access to various Pall Biotech upstream and downstream processing technologies, including bioreactors, mixing and storage, downstream technologies and consumables.

Selecting the right filter integrity test instrument is an important task. An informed, balanced choice will support seamless integration of the instrument into critical processes...
Founded by Dr David B Pall in 1946, Pall Corporation has grown from a company producing filters for the airline industry to a global innovator...
Recent advances in personalised regenerative medicine have been significant. However, further developments are needed to support market and regulatory demands, particularly the development of manufacturing...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology